已发表论文

AMPH-1 作为重要的肿瘤抑制剂可抑制骨肉瘤进展

 

Authors Zhang H, Liu Y, Xu K, Mao K, Han W, Xu F, Wan W, Sun Y

Received 24 June 2019

Accepted for publication 22 October 2019

Published 25 November 2019 Volume 2019:11 Pages 9913—9919

DOI https://doi.org/10.2147/CMAR.S220544

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Cristina Weinberg

Peer reviewer comments 2

Editor who approved publication: Dr Ahmet Emre Eskazan

Introduction: Amphiphysin 1 (AMPH-1) is involved in endocytosis, and its expression is upregulated in osteosarcoma compared with osteofibrous dysplasia.
Methods: We investigated the role of AMPH-1 in osteosarcoma cells via both gain-of-function and loss-of-function experiments.
Results: Knockdown of AMPH-1  in osteosarcoma cells promoted cell cycle progression and cell proliferation and attenuated apoptosis. Notably, silencing AMPH-1  increased osteosarcoma progression in a mouse tumor model. The results obtained upon AMPH-1  knockdown and AMPH-1 overexpression indicates that AMPH-1 is involved in regulating MEK/ERK signaling.
Conclusion: These data suggest that AMPH-1 plays an important role in osteosarcoma and may represent a novel therapeutic target for osteosarcoma treatment.
Keywords: AMPH-1, osteosarcoma, ERK signaling pathway




Figure 1 Influence of AMPH-1 on osteosarcoma progression...